Log In
BCIQ
Print this Print this
 

JGK 263 (formerly JGK-216/263)

  Manage Alerts
Collapse Summary General Information
Company Jeil Pharmaceutical Co. Ltd.
DescriptionGlycogen synthase kinase 3 beta (GSK3B) inhibitor
Molecular Target Glycogen synthase kinase 3 beta (GSK3B)
Mechanism of ActionGlycogen synthase kinase 3 (GSK3) beta inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today